Two Cents | GenomeWeb

Two Cents

The re-opened comment period for feedback to the US Food and Drug Administration on direct-to-consumer genetic testing ends today. The panel focused on molecular and clinical genetics, which is part of the medical devices committee, is seeking “input and comments from interested stakeholders to discuss scientific issues concerning DTC tests,” according to the Federal Register.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: intellectual property landscape of CRISPR genome editing, and more.

A researcher has been convicted of conspiring to steal genetically engineered rice, Reuters reports.

Harvard Medical School's George Church says a woolly mammoth-elephant hybrid is only a few years away, according to the New Scientist.

Intel is ending its sponsorship of the International Science and Engineering Fair, the New York Times reports.